Here is some other vaccine news of note for the week.
> GlaxoSmithKline has reported £1.25 billion ($1.65 billion) in second-quarter vaccine sales, a 16% increase at constant currencies. Reuters story
> The World Health Organization has declared an end to the Ebola outbreak in the Democratic Republic of Congo. Release
> South Korea's SK Bioscience is spending $89 million on a plant to increase vaccine capacity. Pulse story